Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 44,859 shares at $17.39 ($786K) on 2024-01-03, disclosed to the SEC on 2024-01-04.
Scheduled sale ($786k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.95 | 10,385 | $186K | 23.7% |
| 2 | $17.39 | 17,237 | $300K | 38.1% |
| 3 | $17.39 | 17,237 | $300K | 38.1% |
| Total | $17.52 avg | 44,859 | $786K | 100% |
| Filing → |
| RGNX | SELL | 2026-05-13 | $169K | — | Filing → |
| RGNX | SELL | 2026-03-12 | $53K | — | Filing → |
| RGNX | SELL | 2024-03-07 | $730K | — | Filing → |